Analysts, on an average, had expected a profit of Rs 151 crore and revenue of Rs 2,008 crore for the quarter.
The company’s EBITDA (earnings before interest, tax, depreciation and amortization) margin improved to 19.6 per cent, up 185 bps on YoY basis.
The management said fluorochemicals business continued to perform in line with expectations mainly on account of higher sales of Chloromethanes. The specialty chemicals business witnessed robust demand on the back of agro reversal in the fourth quarter, leading to higher sales, it said.
Meanwhile, in a separate regulatory filing, SRF said it has entered into a definitive agreement to sell its engineering plastics business to DSM, the life sciences and materials sciences Company in an all-cash transaction, amounting to Rs 320 crore.
It expects the transaction to provide cash and liquidity to strengthen the company’s balance sheet further. It will also allow company to optimize and focus efforts and resources on developing more-and-more complex technologies within the chemicals business space.
At 03:00 pm, SRF was trading 4 per cent higher at Rs 2,565 on the NSE, as compared to 0.43 per cent rise in the S&P BSE Sensex. The trading volumes on the counter jumped more than eight-fold with a combined 2.74 million shares changed hands on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)